51³Ô¹ÏÍø

Numinus Bioscience explaining research with Psilocybe mushrooms in laboratory at Numinus Bioscience in Nanaimo

Numinus Bioscience explaining research with Psilocybe mushrooms in laboratory at Numinus Bioscience in Nanaimo. Numinus holds Health Canada's only Controlled Drugs and Substances license for Psilocybe mushrooms, which they use to conduct research and development on psychedelic therapeutic products and psychedelic therapy clinical trials. In Nanaimo, British Columbia, Canada, on Wednesday, September 1, 2021.
Numinus Bioscience explaining research with Psilocybe mushrooms in laboratory at Numinus Bioscience in Nanaimo. Numinus holds Health Canada's only Controlled Drugs and Substances license for Psilocybe mushrooms, which they use to conduct research and development on psychedelic therapeutic products and psychedelic therapy clinical trials. In Nanaimo, British Columbia, Canada, on Wednesday, September 1, 2021.
PURCHASE A LICENSE

Get personalized pricing by telling us when, where, and how you want to use this asset.

DETAILS

Restrictions:
For any commercial uses, please contact your local Getty Images representative.
Editorial #:
1338039052
Collection:
Bloomberg
Date created:
September 01, 2021
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:00:10:08
Location:
Nanaimo, British Columbia, Canada
Mastered to:
QuickTime 10-bit ProRes 422 Standard HD 1920x1080 29.97i
Source:
Bloomberg Video RR
Object name:
clip122384_01_20210903